• No results found

ER/PR

Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer.

Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer.

... London. ER, PR, and HER2 were scored in Cambridge while KI67 was scored at the ...for ER, PR, and KI67 nuclear staining, the Ariol system was tuned to distinguish between malignant and ...

13

www.ijcep.com /IJCEP1012011 Case Report Invasive pleomorphic lobular carcinoma, negative for ER, PR and Her/2neu - a case report

www.ijcep.com /IJCEP1012011 Case Report Invasive pleomorphic lobular carcinoma, negative for ER, PR and Her/2neu - a case report

... positive ER/PR and over expression of Her2/neu, a pleomor- phic variant of lobular carcinoma can be triple negative, thereby adding to the challenge of planning the treatment strategy of this aggres- sive ...

6

Study of prevalence of prognostic and predictive immunohistochemical markers er, PR and Her2/neu and their correlation with age in cases of female carcinoma breast in Bihar (Northern India)

Study of prevalence of prognostic and predictive immunohistochemical markers er, PR and Her2/neu and their correlation with age in cases of female carcinoma breast in Bihar (Northern India)

... were ER positive and 55% were PR positive. ER positivity is higher than our study were as PR positivity is almost ...like ER, PR and Her2/neu significantly influence prognosis, ...

5

Correlation of Breast Cancer Subtypes Based on ER, PR and HER2 Expression with Axillary Lymph Node Status

Correlation of Breast Cancer Subtypes Based on ER, PR and HER2 Expression with Axillary Lymph Node Status

... between ER, PR and HER-2/neu expression status, separately and in combinations with axillary lymph node ...of ER, PR and HER-2/neu was evaluated by immune his to ...Results: ER and ...

7

C-MYC and BCL2 Expression in Normal Tissue Around Proliferative Breast Conditions in Relation to ER, PR in a Sample of Iraqi Women

C-MYC and BCL2 Expression in Normal Tissue Around Proliferative Breast Conditions in Relation to ER, PR in a Sample of Iraqi Women

... and ER, PR expression this in concordance of other study 20,21 that reported direct correlation of BCL2 and ER, PR expression in cancer condition than ...cases ER+ had C-MYC ...

6

Effect of Modified and accumulated decoction on serum 
						ER, PR,
						sex hormone, IGF-I and IGF-I in patients with uterine 
						fibroids

Effect of Modified and accumulated decoction on serum ER, PR, sex hormone, IGF-I and IGF-I in patients with uterine fibroids

... with PR, thereby reducing the expression of epidermal growth factor receptor in tumor tissue, slowing the enlargement of tumor body, and playing the role of reducing the volume of uterine fibroids [16] ...of ...

5

A prospective comparison of ER, PR, Ki67 and gene expression in paired sequential core biopsies of primary, untreated breast cancer

A prospective comparison of ER, PR, Ki67 and gene expression in paired sequential core biopsies of primary, untreated breast cancer

... lower ER, PR and Ki67 score on resected material was ...for ER, PR and Ki67 without changing biomarker status (e.g. ER+ to ER-) was 90, 74 and 80 % ...in ER and PR ...

12

Prediction of tumor mutation burden in breast cancer based on the expression of ER, PR, HER-2, and Ki-67

Prediction of tumor mutation burden in breast cancer based on the expression of ER, PR, HER-2, and Ki-67

... Using the log-rank test, significant differences were observed in the DFS curve in terms of TMB (Figure 3). Patients with high TMB (.5.56) had a poor DFS than those with low TMB (83 vs 59 m, P = 0.005). A univariate ...

7

To Assess the Stromal Expression of CD10 in Invasive
Ductal Carcinoma of Breast and It’s Correlation with
Histological Grade, ER, PR AND HER2/neu Expression

To Assess the Stromal Expression of CD10 in Invasive Ductal Carcinoma of Breast and It’s Correlation with Histological Grade, ER, PR AND HER2/neu Expression

... This is to certify that dissertation entitled "To assess the stromal expression of cd10 in invasive ductal carcinoma of breast and its correlation with histological grade, ER, PR AND HER2/ neu ...

129

Molecular Subtypes of Ductal Carcinoma In Situ (DCIS) Identified by Expression of ER, PR, HER2, and Ki-67

Molecular Subtypes of Ductal Carcinoma In Situ (DCIS) Identified by Expression of ER, PR, HER2, and Ki-67

... of ER, PR, HER2, and Ki-67, breast cancer patients were classified into the five molecular subtypes: luminal A, luminal B/HER2 negative, luminal B/HER2 positive, HER2 overexpression, and ...

6

Neurotensin Receptor 1 (NTSR1) Overexpression in Breast Carcinomas Is Common and Independent of ER/PR/Her2 Expression

Neurotensin Receptor 1 (NTSR1) Overexpression in Breast Carcinomas Is Common and Independent of ER/PR/Her2 Expression

... of ER, PR, and ...their ER/PR profiles, the ductal carcinomas (DCs) were subcategorized into ER+/PR+ (21), ER+/PR− (20), and ER−/PR− ...of ...

6

Role of er, pr, her2 and egfr in esophageal carcinoma

Role of er, pr, her2 and egfr in esophageal carcinoma

... of ER, PR, HER2 and EGFR in Esophageal Carcinoma was conducted in the department of pathology at the Sher-i- Kashmir Institute of Medical Sciences (SKIMS) Srinagar, ...

6

Prognostic Implications of ER, PR and HER2/Neu Protein Expression in a Cohort of Breast Carcinoma

Prognostic Implications of ER, PR and HER2/Neu Protein Expression in a Cohort of Breast Carcinoma

... of ER, PR and HER2/neu status and Ki 67 proliferative index are performed routinely in breast carcinoma, in view of the significant clinical implications ...[27]. ER (+) tumours have more favourable ...

6

The Effect of Neoadjuvant Chemotherapy on ER, PR and HER 2 Expression in Breast Cancer

The Effect of Neoadjuvant Chemotherapy on ER, PR and HER 2 Expression in Breast Cancer

... DOI: 10.4236/ym.2019.33017 164 Yangtze Medicine 10% of patients with malignant tumors [1]. Breast cancer is the second most common malignant tumor in women. According to the statistics, the quality of breast cancer ...

13

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium.

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium.

... For ER, PR and HER2, they were lower than previously reported by our group using the Ariol system [14], or an automated scoring algorithm adapted from astronomy [15], possibly Figure ...of ER (A–C) ...

15

Original Article Characteristic of ER /PR and Ki67 value with breast cancer

Original Article Characteristic of ER /PR and Ki67 value with breast cancer

... by ER, PR, HER2 and Ki67 status since the definition of intrinsic sub- types for breast cancer was renovated in 2013 ...of ER, PR, HER2 and Ki67 are the main predictive and prognostic ...

7

Clinico-Pathological Study of
Breast Carcinomas with ER, PR Studies.

Clinico-Pathological Study of Breast Carcinomas with ER, PR Studies.

... WITH ER, PR STUDIES’ under my guidance and supervision in partial fulfillment of the regulation laid down by the 'THE TAMILNADU DR MGR MEDICAL UNIVERSITY, CHENNAI - 32' for ...

109

Correlation of ER, PR and Her-2/Neu with Histological Variants of Breast Carcinoma.

Correlation of ER, PR and Her-2/Neu with Histological Variants of Breast Carcinoma.

... This is to certify that the dissertation entitled “CORRELATION OF ER, PR AND HER-2/neu WITH HISTOLOGICAL VARIANTS OF BREAST CARCINOMA” is a record of bonafide work done by DR. R.D. Puvitha, Post graduate ...

69

Does Metformin affect ER, PR, IGF-1R, β-catenin and PAX-2 expression in women with diabetes mellitus and endometrial cancer?

Does Metformin affect ER, PR, IGF-1R, β-catenin and PAX-2 expression in women with diabetes mellitus and endometrial cancer?

... Objective: Diabetes mellitus, as a risk factor for endometrial cancer (EC), causes an increase in insulin and IGF-1 concentrations in the blood serum. The increase in insulin and IGF-1 are considered mitogenic factors ...

11

To Study the Immunohistochemical expression of BRCA 1 in breast cancer and to assess its association with expression
of ER, PR and HER 2 receptors

To Study the Immunohistochemical expression of BRCA 1 in breast cancer and to assess its association with expression of ER, PR and HER 2 receptors

... trastuzumab which is a form of targeted therapy, whereas they don’t respond well to hormonal treatment. There are also factors similar to that of ER receptor which affects the outcome of the result. Common methods ...

112

Show all 10000 documents...

Related subjects